Bio-Rad Laboratories (BIO) closed at $364.78 in the latest trading session, marking a -0.46% move from the prior day....…
Bio-Rad Laboratories (BIO) closed the most recent trading day at $376.56, moving -0.66% from the previous trading session....…
Crowley, Michael - Vorstand - Tag der Transaktion: 2023-06-15...…
In the latest trading session, Bio-Rad Laboratories (BIO) closed at $361.03, marking a +0.43% move from the previous day....…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
In the latest trading session, Bio-Rad Laboratories (BIO) closed at $372.36, marking a +0.27% move from the previous day....…
Bio-Rads (BIO) process chromatography business witnesses a slowdown in the quarter due to tough comparisons and some softness in the…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Stocks that traded heavily or had substantial price changes Friday: Apple, Expedia rise; Lyft, Bio-Rad Laboratories fall...…
Bio-Rads (BIO) first-quarter results reflect core strength across the Life Science and Clinical Diagnostics segments amid ongoing supply-chain constraints....…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Bio-Rad (BIO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
Bio-Rad Laboratories (BIO) closed the most recent trading day at $461.80, moving -1.17% from the previous trading session....…
Bio-Rad Laboratories (BIO) closed at $479.16 in the latest trading session, marking a -0.49% move from the prior day....…
Here is how Bio-Rad Laboratories (BIO) and CRISPR Therapeutics AG (CRSP) have performed compared to their sector so far this…
Bio-Rad Laboratories (BIO) closed the most recent trading day at $476.83, moving +1.02% from the previous trading session....…
Here is how BridgeBio Pharma (BBIO) and Bio-Rad Laboratories (BIO) have performed compared to their sector so far this year....…
Bio-Rad (BIO) experiences double-digit currency-neutral core revenue growth in the Americas and Asia in Q4....…
DUBLIN, Feb. 23, 2023 /PRNewswire/ -- The "Liquid Biopsy Market Research Report: Forecast (2023-2028)" report has been added to ResearchAndMarkets.coms…
Dublin, Feb. 17, 2023 /PRNewswire/ -- The "Transfection Reagents and Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and…
Excluding COVID-related sales, Life Science revenues at Bio-Rad (BIO) increase 28.1%, primarily driven by Droplet Digital PCR, process chromatography, Western…
Bio-Rad (BIO) delivered earnings and revenue surprises of -4.06% and 2.93%, respectively, for the quarter ended December 2022. Do the…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
read more...…
DUBLIN, Feb. 14, 2023 /PRNewswire/ -- The "Respiratory Diagnostics: Global Strategic Business Report" report has been added to ResearchAndMarkets.coms offering.…
DUBLIN, Feb. 13, 2023 /PRNewswire/ -- Research and Markets The "Peptic Ulcer Testing: Global Strategic Business Report" report has been…
NEW YORK, Feb. 12, 2023 /PRNewswire/ -- The Microbiology Testing Market Method, Product, End-user, and Geography - Forecast and Analysis…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
DUBLIN, Jan. 9, 2023 /PRNewswire/ -- The "Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome…
DUBLIN, Dec. 28, 2022 /PRNewswire/ -- The "In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022" report has been…
Bio-Rads (BIO) underlying Life Science currency-neutral core revenue growth is primarily driven by Western loading, qPCR, process media and antibody…
Multiplexed SARS-CoV-2, Influenza A/B, and RSV and Poliovirus Typing Assays (1, 2 and 3) for the Bio-Rad, QIAGEN, and Thermo…
NEW YORK, Dec. 16, 2022 /PRNewswire/ -- Lateral flow assay components market insights - Vendors: 15+, Including Abbott Laboratories, Ahlstrom…
NEW YORK, Dec. 9, 2022 /PRNewswire/ -- Major players in the neuroscience antibodies & assays market are Abcam PLC, BioLegend…
NEW YORK, Dec. 8, 2022 /PRNewswire/ -- The animal health diagnostics market size is estimated to grow by USD 1,956.81…
DUBLIN, Dec. 2, 2022 /PRNewswire/ -- The "China Biopsy Market, Volume, Size, Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation,…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Bio-Rads (BIO) third-quarter revenues decline mainly as a result of lower COVID-related sales compared with the year-ago period....…
Bio-Rad (BIO) delivered earnings and revenue surprises of 0.39% and 1.34%, respectively, for the quarter ended September 2022. Do the…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Bio-Rad Laboratories stock (NYSE: BIO), a life science research and clinical diagnostic products company, has seen a 48% fall this…
DUBLIN, Oct. 11, 2022 /PRNewswire/ -- The "Automated Cell Counters Market Forecast to 2028 - COVID-19 Impact and Global Analysis…
Das deutsche Biotech-Unternehmen Qiagen und sein US-Wettbewerber Bio-Rad führen Fusionsgespräche. Der Deal zwischen den Diagnostikunternehmen hätte einen Wert von mehr…
Die Unternehmen führen angeblich schon seit einiger Zeit Gespräche. Der Aktienkurs des Dax-Konzerns Qiagen reagierte an der US-Börse mit einem…
Biotechnologie - Die beiden Diagnostikkonzerne Qiagen und Bio-Rad Laboratories verhandeln einem Medienbericht zufolge über eine Fusion....…
Die Unternehmen führen angeblich schon seit einiger Zeit Gespräche. Der Aktienkurs des Dax-Konzerns Qiagen reagierte an der US-Börse mit einem…
Its the circle of life for life-sciences companies. The California-based Bio-Rad Laboratories and the Netherlands-based Qiagen are deep in talks......…
TOKYO (dpa-AFX) - Bio-Rad Laboratories Inc. (BIO) is in talks to merge with Qiagen NV (QGEN) in a deal worth…
The talks have been going on for a while, but any agreement isn’t likely for another few weeks or more…